Loading clinical trials...
Loading clinical trials...
Rationale: For locally advanced esophageal cancer the standard treatment consists of 5 weeks of neoadjuvant chemoradiotherapy (nCRT) followed by surgery. Surgery is currently performed independent of ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
UMC Utrecht
Collaborators
NCT07660627 · Esophageal Adenocarcinoma, Gastric Cancer, and more
NCT06529822 · Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma, and more
NCT06043427 · Gastroesophageal Adenocarcinoma
NCT07217171 · Bladder Cancer, Squamous Cell Carcinoma of the Lung, and more
NCT07452601 · Esophageal Squamous Cell Carcinoma
Amsterdam University Medical Centers, Academic Medical Center
Amsterdam
Antoni van Leeuwenhoek - Netherlands Cancer Institute (NKI-AVL)
Amsterdam
University Medical Center Groningen (UMCG)
Groningen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions